Fluphenazine Decanoate
Fluphenazine Decanoate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Fluphenazine Decanoate; Generic name: FLUPHENAZINE DECANOATE; Manufacturer: Hikma Pharmaceuticals USA Inc..
| Brand name | Fluphenazine Decanoate |
|---|---|
| Generic name | FLUPHENAZINE DECANOATE |
| Manufacturer | Hikma Pharmaceuticals USA Inc. |
| Used for | INDICATIONS AND USAGE Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics). Fluphenazine Decanoate Injection, USP has not been shown effective in the management of behavioral complications in patients with mental retardation. |
| Dosage | DOSAGE AND ADMINISTRATION Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Fluphenazine decanoate injection may be given intramuscularly or subcutaneously. A dry syringe and needle of at least 21 gauge should be used. Use of a wet needle or syringe may cause the solution to become cloudy. To begin therapy with fluphenazine decanoate the following regimens are suggested: For most patient |
| Warnings | WARNINGS Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Fluphenazine decanoate injection is not approved for the treatment of patients with dementia-related psychosis (see BOXED WARNING ). Tardive Dyskinesia: Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements may develop in patients treated with neurol |
| Active ingredient(s) | FLUPHENAZINE DECANOATE |
| Route | INTRAMUSCULAR |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1967dc24-f2a5-4095-baa9-a9d1c5410311 |